BioCorRx (BioCorRx) Interest Expense : $-0.89 Mil (TTM As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is BioCorRx Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. BioCorRx's interest expense for the three months ended in Dec. 2023 was $ -0.29 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.89 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. BioCorRx's Operating Income for the three months ended in Dec. 2023 was $ -0.68 Mil. BioCorRx's Interest Expense for the three months ended in Dec. 2023 was $ -0.29 Mil. BioCorRx did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

BioCorRx Interest Expense Historical Data

The historical data trend for BioCorRx's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioCorRx Interest Expense Chart

BioCorRx Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-1.62

-0.51

-0.57

-1.09

-0.89

BioCorRx Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-0.19	-0.20	-0.19	-0.21	-0.29

BioCorRx Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.89 Mil.

BioCorRx (OTCPK:BICX) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

BioCorRx's Interest Expense for the three months ended in Dec. 2023 was $-0.29 Mil. Its Operating Income for the three months ended in Dec. 2023 was $-0.68 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $0.08 Mil.

BioCorRx's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

BioCorRx did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

BioCorRx (BioCorRx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioCorRx Inc (OTCPK:BICX) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2390 East Orangewood Avenue, Suite 500, Anaheim, CA, USA, 92806

Website

https://www.biocorrx.com

BioCorRx Inc through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders. The BioCorRx Recovery Program is a non-addictive, medication-assisted treatment program for substance abuse that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application.

Executives

Louis C. Lucido	director	2390 EAST ORANGEWOOD AVENUE, SUITE 500, ANAHEIM CA 92806
Joseph J Galligan	director, 10 percent owner	333 SOUTH GRAND AVENUE, 18TH FLOOR, LOS ANGELES CA 90071
Harsha Murthy	director	5209 38TH STREET,NW, WASHINGTON DC 20015
Luisa Ingargiola	director	4826 BLUE JAY CIRCLE, PALM HARBOR FL 34683
Thomas Patrick Welch	officer: Vice President of Operations	10453 SARAH ST., TOLUCA LAKE CA 91602
Kent Emry	director, officer: Chief Executive Officer	2390 EAST ORANGEWOOD AVENUE, SUITE 500, ANAHEIM CA 92806
Brady James Granier	director	13024 DELANO STREET, VALLEY GLEN CA 91401
Lourdes Felix	director, officer: Chief Financial Officer	15 CALLE VERANO, RANCHO SANTA MARGARITA CA 92688
Jorge Jr Andrade	director, officer: Chief Executive Officer	PO BOX 5366, SANTA ANA CA 92704
Muller Neil Terrence Mr	director, officer: President	13231 SANDHURST PLACE, SANTA ANA CA 92705